L'Enoxacin Nelle Infezioni Delle Vie Urinarie: Studio Aperto Non Comparativo

Chartrand S. A. , Scribner R. K. , Weber A. H. , Welch D. F. , Marks M. I. : In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound. Antimicrob. Agents Chemother., 23; 658 (1983).

Chin N. , Neu H. C. : In vitro activity of enoxacin, a quinolone-carboxylic acid, compared with those of norfloxacin, new beta-lactamins, aminoglycosides and trimethoprim. Antimicrob. Agents Chemother., 24; 754 (1983).

Nakamura S. , Minami A. , Katae H. , Inoue S. , Yamagishi J. , Takase Y. , Shimizu M. : In vitro antibacterial properties of AT-2266, a new pyridone-carboxylic acid. Antimicrib. Agents Chemother., 23; 641 (1983).

Nakamura S. , Nakata K. , Katae H. , Minami A. , Kashimoto S. , Yamagishi J. , Takase Y. , Shimizu M. : Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in mice. Antimicrob. Agents Chemother., 23; 742 (1983).

RR-720-00799 (3.9.1983). Early fase II study on AT-2266 (CI-919).

Shimizu M. , Takase J. , Nakamura S. , Katae H. , Inoue S. , Minami A. , Nakata K. , Sakaguchi Y. : AT-2266, a new oral antipseudomonal agent. Proc. 11^th Intern. Congr. Chemother. and 19^th Intersci. Conf. Antimicrob. Agents and Chemoter., vol. I, p. 451.